| 2020 | Development of Acellular Respiratory Mucosal Matrix Using Porcine Tracheal Mucosa | 김한수; 정수연; 최은오 | Article |
| 2019 | Chronic unexplained nausea in adults: Prevalence, impact on quality of life, and underlying organic diseases in a cohort of 5096 subjects comprehensively investigated | 정성애; 정혜경; 심기남; 김성은; 문창모; 태정현 | Article |
| 2017 | CLINICAL IMPACT BY 24 MONTHS ACCORDING TO BCR/ABL1 TRANSCRIPT LEVEL AT 3 AND 6 MONTHS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH RADOTINIB 300MG BID OR IMATINIB | 문영철 | Meeting Abstract |
| 2017 | VERY EARLY MOLECULAR RESPONSE (VEMR) WITH FRONTLINE DASATINIB TREATMENT IS A STRONG PREDICTOR OF LONG-TERM BCR-ABL1 TRANSCRIPT LEVELS IN CHRONIC MYELOID LEUKEMIA PATIENTS: PCR-DEPTH STUDY | 문영철 | Meeting Abstract |
| 2017 | EARLY PREDICTION OF THE MOLECULAR RESPONSE TO BCR-ABL1 TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA | 문영철 | Meeting Abstract |
| 2017 | BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA | 문영철 | Meeting Abstract |
| 2017 | COMPARISON OF MOLECULAR KINETICS AFTER THE FIRST AND SECOND IMATINIB DISCONTINUATION: RESULTS FROM THE KID STUDY | 문영철 | Meeting Abstract |
| 2017 | PEROXIREDOXIN II ACTIVITY HAS IMPORTANT ROLES TO CONTROL ABL TYROSINE KINASE ACTIVITY IN STIS TREATED CML PATIENTS AND ITS POTENTIAL APPLICATION IN IMATINIB RESISTANCE | 문영철 | Meeting Abstract |
| 2017 | VARIABLE NATURAL KILLER CELL ACTIVITY IN HEMATOLOGIC MALIGNANCIES AT DIAGNOSIS | 성주명; 허정원; 문영철 | Meeting Abstract |
| 2017 | Elevation Of Interleukin-33 And Thymic Stromal Lymphopoietin Levels In The Lungs Of Idiopathic Pulmonary Fibrosis | 조용재 | Meeting Abstract |
